World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
14185
World Ranking
3139
National Ranking
121

Paolo Dellabona publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paolo Dellabona sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 177 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paolo Dellabona D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paolo Dellabona sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paolo Dellabona is affiliated with Vita-Salute San Raffaele University in Italy and has contributed extensively to the fields of Medicine and Immunology and Microbiology. Their work spans a range of subfields including Immunology, Oncology, Molecular Biology, Physiology, and Surgery.

Their research focuses primarily on topics related to CAR-T cell therapy research, immune cell function and interaction, T-cell and B-cell immunology, cancer immunotherapy and biomarkers, immunotherapy and immune responses, esophageal cancer research and treatment, and immune cells in cancer.

Recent publications by Paolo Dellabona include:

  • IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer, 2023, Nature
  • In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases, 2023, Cancer Cell
  • Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects, 2022, Cell Reports
  • IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity, 2024, Nature Communications
  • TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells, 2022, Science Immunology

Frequent coauthors collaborating with Paolo Dellabona include Giulia Casorati, Chiara Bonini, Claudia de Lalla, Giovanni Tonon, and Luca Albarello.

Their works have been often published in notable venues such as Nature Communications, Cancer Research, Frontiers in Immunology, UNC Libraries, and Nature, reflecting a consistent presence in journals relevant to immunology and oncology research.

Best Publications

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution

    Laurent Brossay;Mariacristina Chioda;Nicolas Burdin;Yasuhiko Koezuka

  • Laparoscopic Versus Open Colorectal Surgery: A Randomized Trial on Short-Term Outcome

    Marco Braga;Andrea Vignali;Luca Gianotti;Walter Zuliani

  • Expression of two T cell receptor alpha chains: dual receptor T cells

    Elisabetta Padovan;Giulia Casorati;Paolo Dellabona;Stefan Meyer

  • Superantigens interact with MHC class II molecules outside of the antigen groove.

    Paolo Dellabona;Jean Peccoud;Jean Peccoud;John Kappler;Philippa Marrack

  • An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.

    Paolo Dellabona;Elisabetta Padovan;Giulia Casorati;Manfred Brockhaus

  • Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11

    Simona Manici;Tiziana Sturniolo;Maria Adele Imro;Juergen Hammer

  • CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.

    Grazia Galli;Sandra Nuti;Simona Tavarini;Luisa Galli-Stampino

  • Invariant NKT cells sustain specific B cell responses and memory

    Grazia Galli;Paola Pittoni;Elena Tonti;Carmine Malzone

  • Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

    Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  • Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

    M Giovarelli;P Musiani;A Modesti;P Dellabona

  • Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis

    Sandra Nuti;Domenico Rosa;Nicholas M. Valiante;Giulietta Saletti

  • Production of Profibrotic Cytokines by Invariant NKT Cells Characterizes Cirrhosis Progression in Chronic Viral Hepatitis

    Claudia de Lalla;Grazia Galli;Luca Aldrighetti;Raffaella Romeo

  • Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets.

    Andreas Wack;Andrea Cossarizza;Silvia Heltai;Daniela Barbieri

  • Relevance of the Tumor Antigen in the Validation of Three Vaccination Strategies for Melanoma

    Matteo Bellone;Daniela Cantarella;Paola Castiglioni;Maria Cristina Crosti

  • Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

    Maddalena Noviello;Francesco Manfredi;Eliana Ruggiero;Tommaso Perini

  • In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset.

    Paolo Dellabona;Giulia Casorati;Brigitte Friedli;Lena Angman

  • Activation of invariant NKT cells by αGalCer administration protects mice from MOG35–55‐induced EAE: critical roles for administration route and IFN‐γ

    Roberto Furlan;Alessandra Bergami;Daniela Cantarella;Elena Brambilla

  • Neonatal invariant Vα24+ NKT lymphocytes are activated memory cells

    Annalisa D'Andrea;Delphine Goux;Claudia De Lalla;Yasuhiko Koezuka

  • T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification

    Anja Langenkamp;Giulia Casorati;Claudio Garavaglia;Paolo Dellabona

Frequent Co-Authors

Giulia Casorati
Giulia Casorati Vita-Salute San Raffaele University
Matteo Bellone
Matteo Bellone Vita-Salute San Raffaele University
Sergio Abrignani
Sergio Abrignani University of Milan
Antonio Lanzavecchia
Antonio Lanzavecchia Istituto Nazionale Genetica Molecolare
Gennaro De Libero
Gennaro De Libero University Hospital of Basel
Fabio Malavasi
Fabio Malavasi University of Turin
Federica Cavallo
Federica Cavallo University of Turin
Lucia Mori
Lucia Mori University of Basel
H. Robson MacDonald
H. Robson MacDonald University of Lausanne
Angelo Corti
Angelo Corti Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often opens doors to diverse healthcare and research careers. Many students complement their studies with nursing credentials to enhance their job prospects. For those seeking advanced practice roles, exploring accelerated FNP programs can fast-track the path to becoming a Family Nurse Practitioner, blending immunology knowledge with clinical skills.

Individuals without a nursing background looking to enter the healthcare field can consider the best online RN programs for non nurses, which provide comprehensive nursing education while accommodating working professionals.

For those who prefer a swifter route into nursing, ABSN programs with high acceptance rates offer more accessible entry points to obtain a Bachelor of Science in Nursing, a valuable complement to immunology expertise.

Alternatively, fastest and easiest LPN programs provide practical options for those aiming to start a nursing career quickly, which can serve as a stepping stone toward advanced roles in healthcare related to immunology.

Best Scientists Citing Paolo Dellabona

Trending Scientists

Recently Published Articles